CYRX | Cryoport, Inc.

Index- P/E- EPS (ttm)-0.78 Insider Own1.93% Shs Outstand48.36M Perf Week4.38%
Market Cap871.87M Forward P/E- EPS next Y-0.44 Insider Trans-17.96% Shs Float44.61M Perf Month-4.92%
Income-37.50M PEG- EPS next Q-0.17 Inst Own96.00% Short Float / Ratio8.14% / 9.84 Perf Quarter6.88%
Sales247.80M P/S3.52 EPS this Y85.00% Inst Trans-0.47% Short Interest3.63M Perf Half Y19.26%
Book/sh11.17 P/B1.84 EPS next Y25.40% ROA-3.60% Target Price31.00 Perf Year-25.83%
Cash/sh12.29 P/C1.67 EPS next 5Y- ROE-6.90% 52W Range15.63 - 45.36 Perf YTD18.16%
Dividend- P/FCF- EPS past 5Y-21.90% ROI-3.60% 52W High-54.81% Beta1.27
Dividend %- Quick Ratio13.90 Sales past 5Y81.80% Gross Margin43.80% 52W Low31.16% ATR1.33
Employees960 Current Ratio14.50 Sales Q/Q20.10% Oper. Margin-13.70% RSI (14)51.39 Volatility7.20% 6.28%
OptionableYes Debt/Eq0.76 EPS Q/Q49.50% Profit Margin-15.10% Rel Volume1.15 Prev Close20.02
ShortableYes LT Debt/Eq0.76 EarningsMay 04 AMC Payout- Avg Volume369.38K Price20.50
Recom1.60 SMA203.05% SMA50-1.66% SMA200-9.16% Volume425,996 Change2.40%
Date Action Analyst Rating Change Price Target Change
Jan-19-22Upgrade ROTH Capital Neutral → Buy $90
Nov-05-21Downgrade ROTH Capital Buy → Neutral $78 → $90
Oct-19-21Resumed B. Riley Securities Buy $81
Jul-16-21Initiated BTIG Research Buy $80
Mar-15-21Initiated UBS Buy $84
Mar-02-21Resumed Needham Buy $73
Nov-10-20Initiated KeyBanc Capital Markets Overweight $54
Jan-08-20Initiated Stephens Overweight $21
Jul-01-19Resumed Needham Buy $22
Oct-10-18Initiated B. Riley FBR Buy $22
May-25-23 08:02AM
May-12-23 07:15AM
May-04-23 06:05PM
Apr-27-23 10:02AM
08:30AM Loading…
Apr-25-23 08:30AM
Apr-01-23 08:54AM
Mar-28-23 08:30AM
Mar-16-23 03:46AM
Mar-13-23 06:00AM
Mar-08-23 01:15PM
Feb-23-23 06:40PM
Feb-15-23 08:30AM
07:31AM Loading…
Jan-29-23 07:31AM
Jan-26-23 10:55AM
Jan-18-23 08:30AM
Dec-20-22 08:30AM
Dec-19-22 07:15AM
Nov-08-22 06:56AM
Nov-07-22 08:10PM
Nov-03-22 06:45PM
Oct-27-22 08:30AM
Sep-08-22 08:30AM
Aug-08-22 02:42PM
Aug-06-22 10:18AM
09:55AM Loading…
Aug-05-22 09:55AM
Aug-04-22 07:15PM
Jul-28-22 08:30AM
Jul-01-22 08:57AM
May-05-22 07:05PM
Apr-28-22 08:30AM
Apr-20-22 05:59PM
Apr-19-22 12:24PM
Apr-18-22 03:11PM
Mar-30-22 05:00PM
Mar-11-22 03:40PM
Feb-24-22 06:30PM
Feb-23-22 10:00AM
Feb-17-22 03:02PM
Feb-15-22 08:30AM
Feb-09-22 09:29AM
Feb-08-22 09:38AM
Feb-01-22 05:38PM
Jan-31-22 05:35PM
Jan-28-22 05:46AM
Jan-27-22 08:30AM
Jan-26-22 05:38PM
Jan-21-22 05:38PM
Jan-05-22 01:38PM
Dec-16-21 03:38AM
Dec-15-21 01:15PM
Dec-13-21 04:38PM
Dec-05-21 08:05AM
Nov-26-21 04:01PM
Nov-19-21 09:14AM
Nov-15-21 10:45AM
Nov-10-21 12:20AM
Nov-08-21 04:33PM
Nov-05-21 02:48PM
Nov-04-21 11:02PM
Oct-29-21 10:30AM
Oct-28-21 04:15PM
Oct-25-21 01:31PM
Oct-21-21 07:20AM
Oct-20-21 08:00AM
Sep-16-21 11:23AM
Sep-03-21 04:05PM
Aug-27-21 09:44AM
Aug-25-21 08:15AM
Aug-05-21 08:55PM
Jul-29-21 03:04PM
Jul-23-21 02:42AM
Jul-22-21 06:59AM
Jul-21-21 03:20PM
Jun-22-21 08:30AM
May-19-21 08:11AM
May-18-21 07:30AM
May-06-21 08:30AM
May-04-21 06:50PM
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments: Global Logistics Solutions and Global Bioservices. The company offers Cryoport Express Shippers; Cryoport ELITE -80C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20C and -150C. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BERMAN RICHARD JDirectorMay 11Sale21.517,203154,906100,000May 12 06:22 PM
SHELTON JERRELLPresident, CEOMay 10Option Exercise3.24286,377927,861746,458May 12 06:22 PM
STEFANOVICH ROBERTChief Financial OfficerMay 10Option Exercise3.2419,91864,534127,068May 12 06:21 PM
SHELTON JERRELLPresident, CEOMay 10Sale21.63141,1593,053,509605,299May 12 06:22 PM
STEFANOVICH ROBERTChief Financial OfficerMay 10Sale21.9419,918437,023107,150May 12 06:21 PM
BADDOUR LINDADirectorMar 15Option Exercise0.001,111012,474Mar 17 04:16 PM
SHELTON JERRELLChief Executive OfficerMar 15Sale20.792,59954,033432,989Mar 17 04:15 PM
Sawicki Mark WChief Scientific OfficerMar 15Sale20.791,36228,31661,670Mar 17 04:15 PM
STEFANOVICH ROBERTChief Financial OfficerMar 15Sale20.791,06922,22596,695Mar 17 04:15 PM
SHELTON JERRELLChief Executive OfficerMar 13Sale20.143,79876,492435,588Mar 13 09:23 PM
Sawicki Mark WChief Scientific OfficerMar 13Sale20.141,47629,72763,032Mar 13 09:24 PM
STEFANOVICH ROBERTChief Financial OfficerMar 13Sale20.141,15923,34297,764Mar 13 09:25 PM
Sawicki Mark WChief Scientific OfficerMar 09Option Exercise0.002,667064,508Mar 13 09:24 PM
STEFANOVICH ROBERTChief Financial OfficerMar 09Option Exercise0.002,667098,923Mar 13 09:25 PM
SHELTON JERRELLChief Executive OfficerMar 09Option Exercise0.008,2500439,386Mar 13 09:23 PM
BERMAN RICHARD JDirectorDec 01Sale19.637,250142,3160Dec 05 06:07 AM
BERMAN RICHARD JDirectorAug 16Sale43.052,708116,588107,203Aug 16 06:29 PM
Hariri Robert JDirectorAug 11Sale43.292,00086,5817,911Aug 16 06:27 PM